U.S. markets closed

Zynex, Inc. (ZYXI)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
14.13+0.60 (+4.43%)
At close: 4:00PM EST

Zynex, Inc.

9555 Maroon Circle
Englewood, CO 80112
United States
303 703 4906

IndustryMedical Devices
Full Time Employees283

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas SandgaardFounder, Pres, CEO & Chairman523.04k2.24M1959
Mr. Daniel J. MoorheadChief Financial Officer352.86k217.1k1972
Mr. Joseph PapandreaChief Operating Officer272.31kN/A1973
Dr. Raelynn Maloney Ph.D.Director of Communications & Organizational Devel.N/AN/AN/A
Ms. Chelle Van BurkleoVP of SalesN/AN/AN/A
Mr. Dave AnttilaDirector of HRN/AN/AN/A
Mr. Neil FrieryPres & COO of Zynex Monitoring Solutions, Inc.N/AN/AN/A
Mr. Joachim SandgaardInformation Systems Mang.N/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. It offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation device; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and TENSWave, a dual channel TENS device. The company also supplies electrodes for the delivery of electrical current to the body and batteries for use in electrotherapy products; and distributes Comfortrac for cervical traction, JetStream for hot/cold therapy, and LSO Back Braces for lumbar support. In addition, it offers blood volume monitor, a non-invasive medical device for monitoring central blood volume for use in operating and recovery rooms to detect blood loss during surgery and internal bleeding during recovery. The company provides its products for use in pain management and control; and stroke and spinal cord injury rehabilitation. Zynex, Inc. sells its products through direct sales force primarily in the United States. The company was founded in 1996 and is headquartered in Englewood, Colorado.

Corporate Governance

Zynex, Inc.’s ISS Governance QualityScore as of November 2, 2019 is 5. The pillar scores are Audit: 2; Board: 7; Shareholder Rights: 2; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.